Global and United States CRISPR/Cas9 Market Report & Forecast 2024-2031

Report ID: 1836921 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
1 Study Coverage
    1.1 CRISPR/Cas9 Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Introduction
    1.2 Global CRISPR/Cas9 Outlook 2017 VS 2022 VS 2028
        1.2.1 Global CRISPR/Cas9 Market Size for the Year 2017-2028
        1.2.2 Global CRISPR/Cas9 Market Size for the Year 2017-2028
    1.3 CRISPR/Cas9 Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States CRISPR/Cas9 in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of CRISPR/Cas9 Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 CRISPR/Cas9 Market Dynamics
        1.4.1 CRISPR/Cas9 Industry Trends
        1.4.2 CRISPR/Cas9 Market Drivers
        1.4.3 CRISPR/Cas9 Market Challenges
        1.4.4 CRISPR/Cas9 Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 CRISPR/Cas9 by Type
    2.1 CRISPR/Cas9 Market Segment by Type
        2.1.1 Genome Editing
        2.1.2 Genetic Engineering
        2.1.3 gRNA Database/Gene Librar
        2.1.4 CRISPR Plasmid
        2.1.5 Human Stem Cells
        2.1.6 Genetically Modified Organisms/Crops
        2.1.7 Cell Line Engineering
    2.2 Global CRISPR/Cas9 Market Size by Type (2017, 2022 & 2028)
    2.3 Global CRISPR/Cas9 Market Size by Type (2017-2028)
    2.4 United States CRISPR/Cas9 Market Size by Type (2017, 2022 & 2028)
    2.5 United States CRISPR/Cas9 Market Size by Type (2017-2028)
3 CRISPR/Cas9 by Application
    3.1 CRISPR/Cas9 Market Segment by Application
        3.1.1 Biotechnology Companies
        3.1.2 Pharmaceutical Companies
        3.1.3 Academic Institutes
        3.1.4 Research and Development Institutes
    3.2 Global CRISPR/Cas9 Market Size by Application (2017, 2022 & 2028)
    3.3 Global CRISPR/Cas9 Market Size by Application (2017-2028)
    3.4 United States CRISPR/Cas9 Market Size by Application (2017, 2022 & 2028)
    3.5 United States CRISPR/Cas9 Market Size by Application (2017-2028)
4 Global CRISPR/Cas9 Competitor Landscape by Company
    4.1 Global CRISPR/Cas9 Market Size by Company
        4.1.1 Top Global CRISPR/Cas9 Companies Ranked by Revenue (2021)
        4.1.2 Global CRISPR/Cas9 Revenue by Player (2017-2022)
    4.2 Global CRISPR/Cas9 Concentration Ratio (CR)
        4.2.1 CRISPR/Cas9 Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of CRISPR/Cas9 in 2021
        4.2.3 Global CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global CRISPR/Cas9 Headquarters, Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type
        4.3.1 Global CRISPR/Cas9 Headquarters and Area Served
        4.3.2 Global CRISPR/Cas9 Companies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into CRISPR/Cas9 Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States CRISPR/Cas9 Market Size by Company
        4.5.1 Top CRISPR/Cas9 Players in United States, Ranked by Revenue (2021)
        4.5.2 United States CRISPR/Cas9 Revenue by Players (2020, 2021 & 2022)
5 Global CRISPR/Cas9 Market Size by Region
    5.1 Global CRISPR/Cas9 Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global CRISPR/Cas9 Market Size by Region (2017-2028)
        5.2.1 Global CRISPR/Cas9 Market Size by Region: 2017-2022
        5.2.2 Global CRISPR/Cas9 Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America CRISPR/Cas9 Market Size YoY Growth 2017-2028
        6.1.2 North America CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific CRISPR/Cas9 Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific CRISPR/Cas9 Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe CRISPR/Cas9 Market Size YoY Growth 2017-2028
        6.3.2 Europe CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America CRISPR/Cas9 Market Size YoY Growth 2017-2028
        6.4.2 Latin America CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa CRISPR/Cas9 Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa CRISPR/Cas9 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Caribou Biosciences
        7.1.1 Caribou Biosciences Company Details
        7.1.2 Caribou Biosciences Business Overview
        7.1.3 Caribou Biosciences CRISPR/Cas9 Introduction
        7.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022)
        7.1.5 Caribou Biosciences Recent Development
    7.2 Integrated DNA Technologies(IDT)
        7.2.1 Integrated DNA Technologies(IDT) Company Details
        7.2.2 Integrated DNA Technologies(IDT) Business Overview
        7.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Introduction
        7.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022)
        7.2.5 Integrated DNA Technologies(IDT) Recent Development
    7.3 CRISPR Therapeutics
        7.3.1 CRISPR Therapeutics Company Details
        7.3.2 CRISPR Therapeutics Business Overview
        7.3.3 CRISPR Therapeutics CRISPR/Cas9 Introduction
        7.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022)
        7.3.5 CRISPR Therapeutics Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck CRISPR/Cas9 Introduction
        7.4.4 Merck Revenue in CRISPR/Cas9 Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 Mirus Bio
        7.5.1 Mirus Bio Company Details
        7.5.2 Mirus Bio Business Overview
        7.5.3 Mirus Bio CRISPR/Cas9 Introduction
        7.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022)
        7.5.5 Mirus Bio Recent Development
    7.6 Editas Medicine
        7.6.1 Editas Medicine Company Details
        7.6.2 Editas Medicine Business Overview
        7.6.3 Editas Medicine CRISPR/Cas9 Introduction
        7.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022)
        7.6.5 Editas Medicine Recent Development
    7.7 Takara Bio
        7.7.1 Takara Bio Company Details
        7.7.2 Takara Bio Business Overview
        7.7.3 Takara Bio CRISPR/Cas9 Introduction
        7.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022)
        7.7.5 Takara Bio Recent Development
    7.8 Thermo Fisher Scientific
        7.8.1 Thermo Fisher Scientific Company Details
        7.8.2 Thermo Fisher Scientific Business Overview
        7.8.3 Thermo Fisher Scientific CRISPR/Cas9 Introduction
        7.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022)
        7.8.5 Thermo Fisher Scientific Recent Development
    7.9 Horizon Discovery Group
        7.9.1 Horizon Discovery Group Company Details
        7.9.2 Horizon Discovery Group Business Overview
        7.9.3 Horizon Discovery Group CRISPR/Cas9 Introduction
        7.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022)
        7.9.5 Horizon Discovery Group Recent Development
    7.10 Intellia Therapeutics
        7.10.1 Intellia Therapeutics Company Details
        7.10.2 Intellia Therapeutics Business Overview
        7.10.3 Intellia Therapeutics CRISPR/Cas9 Introduction
        7.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022)
        7.10.5 Intellia Therapeutics Recent Development
    7.11 Agilent Technologies
        7.11.1 Agilent Technologies Company Details
        7.11.2 Agilent Technologies Business Overview
        7.11.3 Agilent Technologies CRISPR/Cas9 Introduction
        7.11.4 Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022)
        7.11.5 Agilent Technologies Recent Development
    7.12 Cellecta
        7.12.1 Cellecta Company Details
        7.12.2 Cellecta Business Overview
        7.12.3 Cellecta CRISPR/Cas9 Introduction
        7.12.4 Cellecta Revenue in CRISPR/Cas9 Business (2017-2022)
        7.12.5 Cellecta Recent Development
    7.13 GenScript
        7.13.1 GenScript Company Details
        7.13.2 GenScript Business Overview
        7.13.3 GenScript CRISPR/Cas9 Introduction
        7.13.4 GenScript Revenue in CRISPR/Cas9 Business (2017-2022)
        7.13.5 GenScript Recent Development
    7.14 GeneCopoeia
        7.14.1 GeneCopoeia Company Details
        7.14.2 GeneCopoeia Business Overview
        7.14.3 GeneCopoeia CRISPR/Cas9 Introduction
        7.14.4 GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022)
        7.14.5 GeneCopoeia Recent Development
    7.15 Synthego
        7.15.1 Synthego Company Details
        7.15.2 Synthego Business Overview
        7.15.3 Synthego CRISPR/Cas9 Introduction
        7.15.4 Synthego Revenue in CRISPR/Cas9 Business (2017-2022)
        7.15.5 Synthego Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. CRISPR/Cas9 Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. CRISPR/Cas9 Market Trends
    Table 3. CRISPR/Cas9 Market Drivers
    Table 4. CRISPR/Cas9 Market Challenges
    Table 5. CRISPR/Cas9 Market Restraints
    Table 6. Global CRISPR/Cas9 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States CRISPR/Cas9 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global CRISPR/Cas9 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States CRISPR/Cas9 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top CRISPR/Cas9 Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global CRISPR/Cas9 Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global CRISPR/Cas9 Revenue Share by Player, 2017-2022
    Table 13. Global CRISPR/Cas9 Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CRISPR/Cas9 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR/Cas9 as of 2021)
    Table 15. Top Players of CRISPR/Cas9 in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into CRISPR/Cas9 Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top CRISPR/Cas9 Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States CRISPR/Cas9 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States CRISPR/Cas9 Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global CRISPR/Cas9 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global CRISPR/Cas9 Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global CRISPR/Cas9 Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific CRISPR/Cas9 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa CRISPR/Cas9 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Caribou Biosciences Company Details
    Table 31. Caribou Biosciences Business Overview
    Table 32. Caribou Biosciences CRISPR/Cas9 Product
    Table 33. Caribou Biosciences Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 34. Caribou Biosciences Recent Development
    Table 35. Integrated DNA Technologies(IDT) Company Details
    Table 36. Integrated DNA Technologies(IDT) Business Overview
    Table 37. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product
    Table 38. Integrated DNA Technologies(IDT) Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 39. Integrated DNA Technologies(IDT) Recent Development
    Table 40. CRISPR Therapeutics Company Details
    Table 41. CRISPR Therapeutics Business Overview
    Table 42. CRISPR Therapeutics CRISPR/Cas9 Product
    Table 43. CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 44. CRISPR Therapeutics Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck CRISPR/Cas9 Product
    Table 48. Merck Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. Mirus Bio Company Details
    Table 51. Mirus Bio Business Overview
    Table 52. Mirus Bio CRISPR/Cas9 Product
    Table 53. Mirus Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 54. Mirus Bio Recent Development
    Table 55. Editas Medicine Company Details
    Table 56. Editas Medicine Business Overview
    Table 57. Editas Medicine CRISPR/Cas9 Product
    Table 58. Editas Medicine Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 59. Editas Medicine Recent Development
    Table 60. Takara Bio Company Details
    Table 61. Takara Bio Business Overview
    Table 62. Takara Bio CRISPR/Cas9 Product
    Table 63. Takara Bio Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 64. Takara Bio Recent Development
    Table 65. Thermo Fisher Scientific Company Details
    Table 66. Thermo Fisher Scientific Business Overview
    Table 67. Thermo Fisher Scientific CRISPR/Cas9 Product
    Table 68. Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 69. Thermo Fisher Scientific Recent Development
    Table 70. Horizon Discovery Group Company Details
    Table 71. Horizon Discovery Group Business Overview
    Table 72. Horizon Discovery Group CRISPR/Cas9 Product
    Table 73. Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 74. Horizon Discovery Group Recent Development
    Table 75. Intellia Therapeutics Company Details
    Table 76. Intellia Therapeutics Business Overview
    Table 77. Intellia Therapeutics CRISPR/Cas9 Product
    Table 78. Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 79. Intellia Therapeutics Recent Development
    Table 80. Agilent Technologies Company Details
    Table 81. Agilent Technologies Business Overview
    Table 82. Agilent Technologies CRISPR/Cas9 Product
    Table 83. Agilent Technologies Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 84. Agilent Technologies Recent Development
    Table 85. Cellecta Company Details
    Table 86. Cellecta Business Overview
    Table 87. Cellecta CRISPR/Cas9 Product
    Table 88. Cellecta Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 89. Cellecta Recent Development
    Table 90. GenScript Company Details
    Table 91. GenScript Business Overview
    Table 92. GenScript CRISPR/Cas9 Product
    Table 93. GenScript Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 94. GenScript Recent Development
    Table 95. GeneCopoeia Company Details
    Table 96. GeneCopoeia Business Overview
    Table 97. GeneCopoeia CRISPR/Cas9 Product
    Table 98. GeneCopoeia Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 99. GeneCopoeia Recent Development
    Table 100. Synthego Company Details
    Table 101. Synthego Business Overview
    Table 102. Synthego CRISPR/Cas9 Product
    Table 103. Synthego Revenue in CRISPR/Cas9 Business (2017-2022) & (US$ Million)
    Table 104. Synthego Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. CRISPR/Cas9 Product Picture
    Figure 2. Global CRISPR/Cas9 Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global CRISPR/Cas9 Market Size 2017-2028 (US$ Million)
    Figure 4. United States CRISPR/Cas9 Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States CRISPR/Cas9 Market Size 2017-2028 (US$ Million)
    Figure 6. United States CRISPR/Cas9 Market Share in Global 2017-2028
    Figure 7. CRISPR/Cas9 Report Years Considered
    Figure 8. Product Picture of Genome Editing
    Figure 9. Product Picture of Genetic Engineering
    Figure 10. Product Picture of gRNA Database/Gene Librar
    Figure 11. Product Picture of CRISPR Plasmid
    Figure 12. Product Picture of Human Stem Cells
    Figure 13. Product Picture of Genetically Modified Organisms/Crops
    Figure 14. Product Picture of Cell Line Engineering
    Figure 15. Global CRISPR/Cas9 Market Share by Type in 2022 & 2028
    Figure 16. Global CRISPR/Cas9 Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global CRISPR/Cas9 Market Share by Type (2017-2028)
    Figure 18. United States CRISPR/Cas9 Market Share by Type in 2022 & 2028
    Figure 19. United States CRISPR/Cas9 Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States CRISPR/Cas9 Market Share by Type (2017-2028)
    Figure 21. Product Picture of Biotechnology Companies
    Figure 22. Product Picture of Pharmaceutical Companies
    Figure 23. Product Picture of Academic Institutes
    Figure 24. Product Picture of Research and Development Institutes
    Figure 25. Global CRISPR/Cas9 Market Share by Application in 2022 & 2028
    Figure 26. Global CRISPR/Cas9 Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global CRISPR/Cas9 Market Share by Application (2017-2028)
    Figure 28. United States CRISPR/Cas9 Market Share by Application in 2022 & 2028
    Figure 29. United States CRISPR/Cas9 Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States CRISPR/Cas9 Market Share by Application (2017-2028)
    Figure 31. North America CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. U.S. CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Taiwan CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Philippines CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa CRISPR/Cas9 Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. U.A.E CRISPR/Cas9 Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Caribou Biosciences Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 60. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 61. CRISPR Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 63. Mirus Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 64. Editas Medicine Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 65. Takara Bio Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 67. Horizon Discovery Group Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 68. Intellia Therapeutics Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 69. Agilent Technologies Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 70. Cellecta Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 71. GenScript Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 72. GeneCopoeia Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 73. Synthego Revenue Growth Rate in CRISPR/Cas9 Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Frequently Asked Questions
CRISPR/Cas9 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR/Cas9 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR/Cas9 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Laboratory Balances

Laboratory Balances market is segmented by region (country), players, by Type and by Application. ... Read More